This is a Validated Antibody Database (VAD) review about human NSD3, based on 5 published articles (read how Labome selects the articles), using NSD3 antibody in all methods. It is aimed to help Labome visitors find the most suited NSD3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NSD3 synonym: KMT3F; KMT3G; WHISTLE; WHSC1L1; pp14328; histone-lysine N-methyltransferase NSD3; WHSC1-like 1 isoform 9 with methyltransferase activity to lysine; Wolf-Hirschhorn syndrome candidate 1-like 1; nuclear SET domain-containing protein 3; protein whistle

Proteintech Group
rabbit polyclonal
  • western blot; human; fig s3
Proteintech Group NSD3 antibody (Proteintech, 11345-1-AP) was used in western blot on human samples (fig s3). Sci Rep (2016) ncbi
rabbit polyclonal
In order to characterize SUM-44 breast cancer cells, Proteintech Group NSD3 antibody (ProteinTech, 11345-1-AP) was used . Mol Oncol (2016) ncbi
rabbit polyclonal
  • western blot; human
Proteintech Group NSD3 antibody (Proteintech, 11345-1-AP) was used in western blot on human samples . PLoS ONE (2014) ncbi
Abcam
rabbit monoclonal (EPR13813)
  • western blot; human; loading ...; fig 4a
Abcam NSD3 antibody (Abcam, ab180500) was used in western blot on human samples (fig 4a). Nat Genet (2017) ncbi
Invitrogen
mouse recombinant
  • immunoprecipitation; human; 2 ug
In order to describe a mass spectrometry-based method for scoring immunoprecipitation antibody quality, Invitrogen NSD3 antibody (life tech, 730056) was used in immunoprecipitation on human samples at 2 ug. Nat Methods (2015) ncbi
Articles Reviewed
  1. Papillon Cavanagh S, Lu C, Gayden T, Mikael L, Bechet D, Karamboulas C, et al. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat Genet. 2017;49:180-185 pubmed publisher
  2. García Carpizo V, Sarmentero J, Han B, Grana O, Ruiz Llorente S, Pisano D, et al. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. Sci Rep. 2016;6:32952 pubmed publisher
  3. Irish J, Mills J, Turner Ivey B, Wilson R, Guest S, Rutkovsky A, et al. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ER? in SUM-44 breast cancer cells and is associated with ER? over-expression in breast cancer. Mol Oncol. 2016;10:850-65 pubmed publisher
  4. Marcon E, Jain H, Bhattacharya A, Guo H, Phanse S, Pu S, et al. Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation. Nat Methods. 2015;12:725-31 pubmed publisher
  5. Chen Y, McGee J, Chen X, Doman T, Gong X, Zhang Y, et al. Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS ONE. 2014;9:e98293 pubmed publisher